NCT04288336View on ClinicalTrials.gov

Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 8, 2020

Primary Completion Date

March 25, 2022

Study Completion Date

March 25, 2022

Conditions
Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8Stage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8
Interventions
OTHER

Food Diary

Ancillary studies

OTHER

Preventative Dietary Intervention

Follow intermittent fasting

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT04288336 - Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy | Biotech Hunter | Biotech Hunter